Company Registration No. 15376343 (England and Wales)
Advancare Therapies Ltd
Unaudited accounts
for the year ended 31 December 2025
Advancare Therapies Ltd
Unaudited accounts
Contents
Advancare Therapies Ltd
Company Information
for the year ended 31 December 2025
Company Number
15376343 (England and Wales)
Registered Office
Brookfield Court Selby Road
Garforth
Leeds
LS25 1NB
United Kingdom
Accountants
DJB Accounting Ltd
34 Knockmoyle Drive
Greystone Road
Antrim
BT41 1HE
Advancare Therapies Ltd
Accountants' report
Accountants' report to the director of Advancare Therapies Ltd on the preparation of the unaudited statutory accounts for the year ended 31 December 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of
Advancare Therapies Ltd for the year ended
31 December 2025 as set out on pages
5 -
7 from the company's accounting records and from information and explanations you have given us.
This report is made solely to the Board of Directors of Advancare Therapies Ltd, as a body, in accordance with the terms of our engagement letter dated 1 March 2025. Our work has been undertaken solely to prepare for your approval the accounts of Advancare Therapies Ltd and state those matters that we have agreed to state to them, as a body, in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Advancare Therapies Ltd and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that Advancare Therapies Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Advancare Therapies Ltd. You consider that Advancare Therapies Ltd is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the accounts of Advancare Therapies Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.
DJB Accounting Ltd
34 Knockmoyle Drive
Greystone Road
Antrim
BT41 1HE
15 August 2026
Advancare Therapies Ltd
Statement of financial position
as at 31 December 2025
Cash at bank and in hand
48,680
61,969
Creditors: amounts falling due within one year
(31,110)
(29,593)
Net current assets
17,570
32,376
Called up share capital
100
100
Profit and loss account
41,350
32,276
Shareholders' funds
41,450
32,376
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 22 August 2026 and were signed on its behalf by
Stefano Colaci
Director
Company Registration No. 15376343
Advancare Therapies Ltd
Notes to the Accounts
for the year ended 31 December 2025
Advancare Therapies Ltd is a private company, limited by shares, registered in England and Wales, registration number 15376343. The registered office is Brookfield Court Selby Road, Garforth, Leeds, LS25 1NB, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws.
Deferred tax assets and liabilities are not discounted.
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
Government grants in relation to tangible fixed assets are credited to profit and loss account over the useful lives of the related assets, whereas those in relation to expenditure are credited when the expenditure is charged to profit and loss.
The director has considered the Company’s financial position, expected trading performance and cash flow requirements for a period of at least twelve months from the date of approval of these financial statements.
Having considered the available information, the director has reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, the financial statements have been prepared on the going concern basis.
Advancare Therapies Ltd
Notes to the Accounts
for the year ended 31 December 2025
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
20% Straight Line
4
Tangible fixed assets
Fixtures & fittings
5
Investments
Other investments
Valuation at 1 January 2025
-
Valuation at 31 December 2025
21,000
6
Creditors: amounts falling due within one year
2025
2024
Taxes and social security
11,914
13,982
Loans from directors
19,196
15,611
7
Average number of employees
During the year the average number of employees was 1 (2024: 1).